Source: Eur Respir J 2001; 18: 347-356
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Koslowski R., Pfeil U., Fehrenbach H., Kasper M., Skutelsky E., Wenzel K-W.. Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat. Eur Respir J 2001; 18: 347-356

Member's Comments

No comment yet.

Related content which might interest you: Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat. Source: Eur Respir J 2001; 18: 1081 Year: 2001 Collagen VI-producing macrophages mediate lung fibrosis Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Role of endothelin in lung fibrosis Source: Eur Respir Rev 2008; 17: 145-150 Year: 2008 Decreased VEGF concentration in lung tissue and vascular injury during ARDS Source: Eur Respir J 2005; 25: 139-146 Year: 2005 Enhancement of bleomycin-induced lung fibrosis in tenascin C-deficient mice Source: Eur Respir J 2004; 24: Suppl. 48, 103s Year: 2004 Inhibition of pulmonary collagen-I, III and fibrotic cytokins in bleomycin induced pulmonary fibrosis by okam J201 Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005 Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis Source: Eur Respir J 2004; 24: 57-65 Year: 2004 Surface enolase-1 mediated cell migration and lung fibrosis in bleomycin-induced mice Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Collagen synthesis in an in vivo rat model of ventilator-induced lung injury Source: Eur Respir J 2006; 28: Suppl. 50, 397s Year: 2006 Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Differences in proteoglycan deposition in the airways of moderate and severe asthmatics Source: Eur Respir J 2007; 29: 71-77 Year: 2007 BIBF1120 inhibits fibroblasts proliferation and production of the extracellular matrix protein fibulin-1 Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 PBI-compound, a novel first-in-class anti-fibrotic compound, inhibits CTGF and collagen production in murine and human fibroblasts, and reduces lung fibrosis in the bleomycin-induced lung fibrosis model Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Endothelin-1 induced connective tissue growth factor expression in human lung fibroblasts by ETAR-dependent JNK/AP-1 pathway Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Matrix metalloproteinase (MMP)-2 production by fibroblasts and mast cells: the role in pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 455s Year: 2004 Telomerase activity in bleomycin-induced epithelial cell apoptosis and lung fibrosis Source: Eur Respir J 2007; 30: 205-213 Year: 2007 Uncoupling the pro-fibrotic effects of TGF-beta1 versus tissue hardening in lung fibroblasts Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Inhibition of the Arp2/3 complex inhibits lung myofibroblast differentiation in vitro and attenuates bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019